18.49 USD
▲-0.09+1.71%
盘后 18.18 0.00%
2026-08-03
市值
$2.08B
市盈率
—
EPS
-1.62
股息率
—
52 周区间
15.96 – 39.64
成交量
290.02K
Beta
0.76
目标价
33.30
52W 低 15.9652W 高 39.64
价格走势
公司简介
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacter...